Becerril S, Rodríguez A, Catalán V, Sáinz N, Ramírez B, Gómez-Ambrosi J, Frühbeck G. Transcriptional analysis of brown adipose tissue in leptin-deficient mice lacking inducible nitric oxide synthase: evidence of the role of Med1 in energy balance. Physiol Genomics 44: 678 -688, 2012. First published May 8, 2012 doi:10.1152/physiolgenomics.00039.2012.-Leptin and nitric oxide (NO) are implicated in the control of energy homeostasis. The aim of the present study was to examine the impact of the absence of the inducible NO synthase (iNOS) gene on the regulation of energy balance in ob/ob mice analyzing the changes in gene expression levels in brown adipose tissue (BAT). Double knockout (DBKO) mice simultaneously lacking the ob and iNOS genes were generated and the expression of genes involved in energy balance including fatty acid and glucose metabolism as well as mitochondrial genes were analyzed by microarrays. DBKO mice exhibited an improvement in energy balance with a decrease in body weight (P Ͻ 0.001), total fat pads (P Ͻ 0.05), and food intake (P Ͻ 0.05), as well as an enhancement in BAT function compared with ob/ob mice. To better understand the molecular events associated with this improvement, BAT gene expression was analyzed. Of particular interest, gene expression levels of the key subunit of the Mediator complex Med1 was upregulated (P Ͻ 0.05) in DBKO mice. Real-time PCR and immunohistochemistry further confirmed this data. Med1 is implicated in adipogenesis, lipid metabolic and biosynthetic processes, glucose metabolism, and mitochondrial metabolic pathways. Med1 plays an important role in the transcriptional control of genes implicated in energy homeostasis, suggesting that the improvement in energy balance and BAT function of the DBKO mice is mediated, at least in part, through the transcription coactivator Med1. energy homeostasis; metabolism; thermogenesis; mitochondrial function ENERGY HOMEOSTASIS CONSTITUTES a tightly regulated process that requires a balance between energy intake and expenditure (26), integrating several biological systems that include behavioral and metabolic actions. Energy expenditure plays an important role in maintaining body weight and is composed by three principal components: basal metabolic rate, physical activity, and adaptive thermogenesis. Obesity results from a long-term positive energy balance, where energy intake surpasses energy expenditure. Both brown and white adipose tissue (BAT and WAT, respectively) are active organs involved in the regulation of energy homeostasis and obesity.
energy homeostasis; metabolism; thermogenesis; mitochondrial function ENERGY HOMEOSTASIS CONSTITUTES a tightly regulated process that requires a balance between energy intake and expenditure (26) , integrating several biological systems that include behavioral and metabolic actions. Energy expenditure plays an important role in maintaining body weight and is composed by three principal components: basal metabolic rate, physical activity, and adaptive thermogenesis. Obesity results from a long-term positive energy balance, where energy intake surpasses energy expenditure. Both brown and white adipose tissue (BAT and WAT, respectively) are active organs involved in the regulation of energy homeostasis and obesity.
BAT constitutes an important mediator of sympathetically mediated nonshivering thermogenesis (8, 25) . In contrast to WAT, which is mainly composed by mature unilocular adipocytes with a single large lipid droplet that fills the majority of the cytoplasm, BAT is made of smaller mature multilocular adipocytes, which are characterized by multiple small lipid droplets with densely packed mitochondria (31) .
The BAT-specific proton transporter uncoupling protein-1 (Ucp-1) mediates heat production by uncoupling the respiratory chain from oxidative phosphorylation (7) . Transcriptional regulation of the Ucp1 gene is controlled by regulatory elements involved in white and brown adipogenesis, mitochondrial biogenesis as well as in glucose and lipid metabolism (20) .
Leptin, the product of the ob gene, is a 16 kDa cytokine-like protein predominantly expressed in adipocytes (63) . Initially, leptin was thought to regulate body weight through effects on food intake and energy expenditure at the hypothalamic level (28) . It is noteworthy that leptin increases energy expenditure via the activation of the sympathetic nerve activity and the turnover of norepinephrine in BAT (62) . Moreover, leptin induces the gene expression of the PPAR␥ coactivator-1␣ (Pgc1a) and Ucp1 leading to an increased thermogenesis (41, 55) . Leptin also plays a key role in lipid metabolism by stimulating fatty acid oxidation and lipolysis in adipocytes (22, 23) . Furthermore, leptin reportedly participates in glucose homeostasis improving insulin sensitivity (30) . In this sense, leptin-deficient ob/ob mice exhibit marked obesity, hyperphagia, insulin resistance, and a defective functional BAT, among other metabolic alterations.
Adipose tissue constitutes an important source of nitric oxide (NO), a free radical involved in many physiological processes. It is produced from L-arginine in a reaction catalyzed by NO synthase (NOS). Three isoforms of NOS enzymes are known: neuronal (nNOS) and endothelial (eNOS), which are constitutively expressed, and inducible (iNOS), which is regulated in response to proinflammatory stimuli (44) . The presence of metabolically active eNOS and iNOS in brown adipocytes suggests the involvement of NO in BAT function and regulation (51) . NO affects lipid metabolism in adipose tissue including both lipogenesis and lipolysis. NO reportedly mediates the stimulatory effect of leptin on lipolysis in adipose tissue of rats (27) . Additionally, the deletion of the iNOS gene has been shown to prevent high-fat diet-induced insulin resistance (51) . Our group (21, 27, 52) and others (19, 56) have described a functional relationship between leptin and iNOS. In this context, we previously generated a double knockout mouse (DBKO) lacking simultaneously both genes. The observed reduction in fat mass, the increased food efficiency ratio (FER), the improved glucose and lipid metabolism, and the smaller adipocyte size compared with ob/ob mice led us to postulate that DBKO promote energy dissipation. This effect was mediated, at least in part, through the improvement of brown fat cell function (2, 37) . We performed microarray analyses of BAT to comprehensively characterize and better understand the altered genes and networks that control the improvement of energy homeostasis in DBKO mice.
MATERIALS AND METHODS

Generation of DBKO mice lacking the ob and iNOS genes.
A DBKO mouse simultaneously lacking the ob and the iNOS genes was bred as previously described (2) . Mice had free access to water and were fed ad libitum a chow diet (24) . Body weight and food intake were registered twice weekly. The FER was determined as body weight gained per week divided by total energy (kilocalories) consumed over this period (18) . Body temperature was assessed by measuring rectal temperature using a rectal thermoprobe (YSI 4600 Series Precision Thermometers; YSI Temperature, Dayton, OH).
Blood and tissue collection. Twelve-week-old mice were fasted for 6 h and killed by CO 2 inhalation. Blood and brown fat samples were obtained as previously described (2, 38) . All experimental procedures conformed to the European Guidelines for the Care and Use of Laboratory Animals (Directive 86/609), and the study was approved by the Ethical Committee for Animal Experimentation of the University of Navarra (042/03 and 041/08).
Blood measurements. Serum glucose, triglycerides (TG), total cholesterol, free fatty acids (FFA), and glycerol were measured by enzymatic methods using commercially available kits as described before (2, 54) . Insulin and adiponectin were determined by ELISA. Intra-and interassay coefficients of variation for measurements of insulin and adiponectin were 3.5 and 6.3%, respectively, for the former, and 5.6 and 7.2%, for the latter (2, 54) .
Microarray experiments and analysis. Total RNA was extracted as described earlier (2, 54) and gene expression profiling was performed using the Agilent Whole Mouse Genome array (G4121B; Agilent Technologies, Santa Clara, CA) containing Ͼ41,000 mouse genes and transcripts. Twenty microarrays were hybridized (one array per mouse, five arrays per experimental group). Gene Ontology (GO) analysis identified clusters of biological processes. The GO database (http://babelomics.bioinfo.cipf.es) was used in conjunction with GeneSpring (http://www.agilent.com/chem/genespring) to identify pathways and functional groups of genes.
Real-time PCR. For first-strand cDNA synthesis constant amounts of total RNA were reverse transcribed using random hexamers as primers and M-MLV reverse transcriptase as previously described (10, 36) . The transcript levels for Med1 were quantified by real-time PCR as detailed earlier. To validate the microarray data, a number of representative genes involved in energy homeostasis were selected to be individually studied by real-time PCR. Primers and probes were designed using the software Primer Express 2.0 (Applied Biosystems) and purchased from Genosys (Sigma, St. Louis, MO). Supplemental Table S1 (see supporting information) shows the primers and Taqman probes used for Med1, Prdm16, Sirt1, Sirt3, Ucp1, and Ucp3. 1 We used the same conditions previously described by Catalán et al. (9) to measure the DNA amplification.
Western blot studies. Tissues were homogenized and protein content was measured as described earlier (2, 52) . Blots were incubated overnight at 4°C with primary antibodies against Ucp-1 and Ucp-3 (Abcam, Cambridge, UK) at 1:10,000 and 1:8,000, respectively; Sirt-1 (Abcam) at 1:1,000; Sirt-3 (Cell Signaling Technology, Danvers, MA) at 1:1,000; or ␤-actin (Sigma) at 1:5,000.
Immunohistochemistry of Med1. Immunohistochemical detection of the Med1 protein was carried out in BAT, as described before (2, 11, 53) . Sections were incubated overnight at 4°C with rabbit monoclonal anti-Med1 antibody (R&D Systems, Minneapolis, MN) diluted 1:100 in Tris-buffered saline (TBS). After three washes (5 min each) with TBS, sections were incubated with horseradish peroxidase-conjugated anti-rabbit IgG antibody (Amersham Biosciences, Buckinghamshire, UK) diluted 1:200 in TBS for 30 min at room temperature.
Statistical analysis. Data are presented as means Ϯ SE. Differences between groups were assessed by a two-way ANOVA. In case of interaction between factors (lack of the iNOS or ob genes), a one-way ANOVA followed by least significant difference (LSD) post hoc tests were applied. Furthermore, statistical comparisons of microarray data to identify differentially expressed genes across different groups were per- 1 The online version of this article contains supplemental material. 
RESULTS
iNOS deletion ameliorates obesity in ob/ob mice. Physiological variables of 12-wk-old experimental animals are shown in Table 1 . As expected, body weight gain was significantly (P Ͻ 0.001) greater in leptin-deficient mice compared with wildtype mice, being associated with a significantly (P Ͻ 0.001) increased epididymal, subcutaneous, and total fat accretion in ob/ob and DBKO mice. Interestingly, as previously described, the ob/ob mice lacking the iNOS gene (DBKO mice) exhibited a decreased body weight (P Ͻ 0.001) together with significantly (P Ͻ 0.05) smaller subcutaneous and total fat depots compared with ob/ob mice. The weight gain of ob/ob mice during the 12 wk of the study was significantly elevated compared with DBKO mice (34.7 Ϯ 0.6 vs. 26.5 Ϯ 1.1 g, P Ͻ 0.001). The difference in body fat gain in DBKO mice was accompanied by a reduced (P Ͻ 0.05) food intake and a lower FER compared with ob/ob mice. Moreover, the analysis of the rectal temperature revealed that iNOS deficiency improved the reduced rectal temperature of ob/ob mice (P Ͻ 0.001).
Leptin deficiency was related to insulin resistance, as shown by the increased circulating concentrations of glucose, insulin, and homeostasis model assessment (HOMA) index (P Ͻ 0.001), as well as by the low adiponectin levels ( Table 1) . Absence of iNOS in ob/ob mice improved glucose metabolism Differential expression of genes is indicated as fold change presenting only the genes that were significantly different (P Ͻ 0.05) between groups.
iNOS REGULATES Med1 IN BROWN ADIPOSE TISSUE by decreasing the HOMA index (P Ͻ 0.01) and increasing adiponectin levels although differences only reached a marginal significance (P ϭ 0.08). Furthermore, iNOS deletion significantly reduced FFA concentrations in wild-type and ob/ob mice (P Ͻ 0.01).
Regulation of energy homeostasis.
To analyze the effect of the absence of iNOS in ob/ob mice on the regulation of energy homeostasis, gene expression profiles of BAT of the experimental mice were assessed by microarray technology. This analysis showed that the expression of a total of 3,530 transcripts was differentially regulated in ob/ob mice. Of these, 43.6% were upregulated and 56.4% were downregulated in ob/ob mice. The absence of iNOS altered the expression of 317 transcripts (44.8% were upregulated and 55.2% were downregulated). Changes in the BAT gene expression profile of DBKO were also observed, with 28 genes showing a significant (P Ͻ 0.05) change compared with ob/ob mutants (78.9% upregulated genes, and 21.4% downregulated genes). The GO analysis revealed that the set of genes with altered expression levels due to leptin deficiency represents a broad spectrum of biological processes (the complete GO analyses are available in the supporting information, Supplemental Tables S2-S5). We focused on the effects of the lack of leptin and iNOS in the expression of genes related to lipid and glucose metabolism, as well as in mitochondrial genes to gain further insight into the impact of the absence of both genes in metabolism and energy balance. Table 2 shows that the absence of the ob gene altered the expression of a large number of genes involved in lipid metabolism. In this sense, ob/ob mice exhibited increased mRNA levels of genes that participate in lipid biosynthesis (Fads3 and Scd2), fatty acid transport (Cpt1a and Fabp3), as well as transport and/or storage of free fatty acids/triglycerides in lipid droplets (Cav1) (17, 29) . Nonetheless, leptin-deficient mice showed a decrease in the transcriptional factors that regulate the expression of the lipogenic genes Srebp1 and 2. Accordingly, genes encoding lipogenic enzymes, such as Lpl, Fas, or Elovl6 were also downregulated.
Effect of leptin and iNOS deficiency on gene expression reveals changes in lipid and glucose metabolism in BAT.
Lack of the iNOS gene was associated with a downregulation of genes related to lipid metabolism (Lpin1, Acaca, Fasn, Scd). Interestingly, the microarray analysis showed that iNOS deficiency in ob/ob mice increased the expression levels of Med1, a key subunit of the Mediator complex that regulates PPAR␥-stimulated adipogenesis and transcriptional activity (33, 34) , and Pafah1b1, also involved in lipid metabolism.
The absence of leptin altered the expression of many genes involved in glucose metabolism. The microarray analysis showed that the absence of leptin increased the expression of genes involved in glucose metabolism (Tgfb, Lctl), glycolysis (Hk1), gluconeogenesis (Pck2), or transcriptional regulators such as members of the Atf family (Table 3 ). In addition, leptin deficiency decreased the expression of genes related to glu- cose, inositol, or insulin signaling such as p38Mapk (also known as Mapk14), Impa1, Pik3ca, Itpka, and Ampk, among others. The mRNA expression of genes related to glycerol metabolism (Gyk), glycolysis (Bpgm), and glucogen metabolism (Ppp1r1a) was increased in iNOS-deficient mice (Table 3) . Changes in the expression of genes regulating mitochondrial metabolism. Due to the relevance of the mitochondria in energy homeostasis, genes involved in mitochondrial processes together with the most altered mitochondrial pathways were studied. Absence of leptin repressed the expression of genes related to protein transmembrane transport members of the Timm family or the uncoupling protein Ucp3. Furthermore, leptin deficiency repressed genes implicated in the regulation of mitochondrial transcription (Tfam and Tfb2m), essential in DNA replication in brown adipocytes ( Table 4 ). The iNOS deficiency increased the expression levels of mitochondrial genes involved in fatty acid metabolism, such as Gpam, and the simultaneous lack of the ob and iNOS genes repressed the expression of the translocase of inner mitochondrial membrane Timm22 (Table 4) .
Analysis of common genes in the expression profiles. Exploration of the major biological processes of the genes differentially expressed in DBKO mice according to the GO analysis reveals that most of these genes are related to primary (65%) and cellular (59%) metabolic processes or cellular component organization and biogenesis (52%) (Fig. 1A) . A Venn diagram was constructed to identify the common genes and the relationship between the different comparisons in an attempt to overcome the influence of the absence of both genes (Fig. 1B) . The absence of leptin disclosed 3,530 differentially expressed transcripts when compared with wild-type mice, whereas the lack of both genes modified the expression of 3,689 genes compared with wild-type animals. A total of 28 transcripts were differentially expressed in DBKO mice compared with ob/ob mice, whereas in the ob/ob vs. wild-type comparison 3,530 transcripts were differentially expressed, with 16 transcripts being common to both comparisons. Therefore, 16 of the 3,530 transcripts of ob/ob mice modified their expression after we eliminated the iNOS gene. Table 5 shows the altered genes in ob/ob mice whose expression was reverted after the iNOS deletion. Moreover, only six genes were common between the three comparisons as illustrated in the Venn diagram. These genes participate in catabolic processes (Ube2w and Ovca2), immune responses (Gstm2 and Tgtp), protein transport (Timm22), and energy homeostasis (Med1). The major change in gene expression was observed in Med1, with ob deficiency repressing its expression, whereas the iNOS deletion in ob/ob mice induced a twofold increase in its expression.
DBKO mice display changes in gene and protein expression levels of Med1. Using semiquantitative real-time PCR, we assessed gene expression in RNA samples obtained from BAT samples of the individual mice that were used for the microar- (Fig. 2) . Similar results in the protein expression levels of Sirt1 and Sirt3, as well as of Ucp1 and Ucp3 were obtained by Western blot studies (Fig. 3) . As shown in Fig. 4A , the gene expression of Med1 was upregulated in iNOS-deficient mice compared with the levels of wild-type mice. DBKO mice exhibited a significantly increased expression of this gene compared with ob/ob mice (P Ͻ 0.05). Immunohistological analyses showed positive staining for Med1 in brown adipocytes in all experimental groups. Interestingly, the immunostaining of this protein was markedly increased in iNOS-deficient and DBKO mice and decreased in ob/ob animals compared with wild types (Fig. 4B) , which was associated with an improvement in the BAT phenotype.
DISCUSSION
The important interplay between the ob and iNOS genes in energy homeostasis was shown in previous studies with the DBKO mice lacking simultaneously both genes (2, 57). Leptindeficient mice develop marked obesity and hyperphagia, accompanied by several physiological alterations such as insulin resistance, hypothermia, and increased food efficiency, as previously described (63) . Mice lacking the iNOS gene are protected from developing diet-induced obesity, exhibiting reduced fat pads and increased body temperature (2, 35) . We herein further show that deletion of iNOS exerts a significant impact on energy homeostasis through the increase of energy expenditure and the decrease of food intake. DBKO mice weighed significantly less than ob/ob mutants at the end of the study due to a reduction in food intake together with an increase in rectal temperature and FER. These findings confirm previous observations of our group proposing that ablation of the Differential expression of genes is indicated as fold change with respect to the WT group presenting only the genes that were significantly different (P Ͻ 0.05). Lightface indicates upregulated genes, and boldface indicates downregulated genes.
iNOS REGULATES Med1 IN BROWN ADIPOSE TISSUE
iNOS gene improves the energy balance of ob/ob mice by decreasing energy intake and by increasing energy expenditure (2) .
Obese ob/ob mice exhibit alterations in lipid and glucose metabolism, while deletion of the iNOS gene reveals a protection from developing insulin resistance together with an improved lipid metabolism (2). Thus, we aimed to identify genes related to fatty acid and glucose metabolism altered by deficiency of both genes in the brown fat depot. In the present study, BAT samples were analyzed for mRNA presence of Ͼ41,000 transcripts by microarray analysis. Using the GO terms of biological processes, we identified the genes related to lipid and glucose metabolism as well as mitochondrial genes affected by the simultaneous deficiency of the ob and iNOS genes, which would help us to understand better the impact of the absence of both genes on energy balance.
Lipogenesis constitutes a key event in the energy storage system. It is well known that ob/ob mice exhibit an increased de novo lipogenesis in liver and adipose tissue as well as a reduced lipolysis (12) . Moreover, leptin exerts a stimulatory effect on lipolysis through NO-dependent mechanisms. In the present study, 145 genes implicated in lipid metabolic processes are differentially expressed in ob/ob mice. Most of the upregulated genes can be mapped to the lipid biosynthetic process, including Fads3, which participates in the biosynthesis of long chain polyunsaturated fatty acids (49), Scd2, essential for PPAR␥ expression and the biosynthesis of monounsaturated fatty acids (16, 47) or Rarres, which codifies for the chemoattractant protein chemerin associated with obesity and metabolic syndrome (6, 9) . These results, although obtained in BAT, may explain the increased lipogenesis observed in leptindeficient mice and the "white adipose-like" appearance of BAT in these mice. Paradoxically, a reduced expression of genes codifying for enzymes that catalyze the biosynthesis of fatty acids such as Fasn and Scap (15, 42) together with the transcription factor Srebp1 (39) may represent an attempt to reduce lipid storage in ob/ob mice, similar to what happens in human obesity (48) . The iNOS deficiency represses the expression of genes involved in lipogenesis and fatty acid synthesis, such as Acyl, Acc, Fasn, or Scd2. We herein showed that mice lacking the ob and iNOS genes exhibit an increased expression of Med1 and Pafah1b1, both implicated in adipocyte differentiation and lipid catabolism (13) . These data may explain the improvement in lipid homeostasis in the context of iNOS deficiency, since mice lacking the iNOS gene exhibit decreased serum FFA, TG and total cholesterol levels.
Leptin deficiency is also associated with an altered carbohydrate metabolism; ob/ob mice develop severe insulin resistance with hyperglycemia and hyperinsulinemia (30, 50) . In this sense, our data indicate that 91 genes implicated in carbohydrate metabolism are differentially expressed in the context of leptin deficiency. Leptin absence represses the gene expression of p38Mapk, a kinase implicated in insulin-mediated glucose uptake and in the inhibition of preadipocyte differentiation through the downregulation of C/EBP␤ and PPAR␥ factors. An important role of Tgfb in the regulation of glucose and energy homeostasis, together with a positive correlation between Tgfb levels and adiposity, has been described (61) . Indeed, Tgfb is significantly increased in BAT of ob/ob mutants. This fact may contribute to the impaired metabolic profile observed in leptin-deficient mice. Furthermore, genes involved in insulin postreceptor responses are downregulated, including Impa1, Pik3ca, and Itpka. Accordingly, Pdk1 and Pdk2, which phosphorylate downstream effectors of PI3K signaling pathways, and Ampk are also downregulated, indicating an altered glucose metabolism. iNOS-knockout mice are protected from developing obesity and insulin resistance induced by high-fat feeding (32, 51) . Our study provides evidence that iNOS deficiency improves carbohydrate metabolism decreasing glucose and insulin levels as well as increasing adiponectinemia. These results are in accordance with previous studies (2, 32, 57) . Moreover, we found that the expression of genes related to glycerol metabolism (Gyk) or genes that improve the glucose metabolism (Impa1, Gyk, and Ampk) are increased in iNOS-deficient mice.
Several studies have reported the importance of mitochondria in fatty acid oxidation, insulin sensitivity, and energy metabolism (1, 60) . In fact, the impairment in mitochondrial function due to alterations in its morphology, number, or oxidative capacity results in a decrease in glucose and fatty acid oxidation and insulin resistance (43) . Mitochondrial biogenesis is downregulated in adipose tissue of obese mice leading to a defective cellular energy metabolism (58) . In this sense, leptin has been shown to activate mitochondrial biogenesis, and leptin deficiency is associated with impaired mitochondrial function (5) . In the context of leptin absence we found that members of the Mrp family implicated in mitochondrial protein synthesis as well as translocase membrane proteins involved in transmembrane transport (Tomm, Timm, and Slc families) are downregulated. Furthermore, the expression level of genes implicated in electron chain transport (Txn2, Cyb5b, and Ndufb8) and transcription factors involved in the replication of mitochondrial DNA, such as the mitochondrial transcription factor A (Tfam) or B2 (Tfb2m), is also reduced. Moreover, leptin deficiency reduces the expression levels of the transcriptional co-regulator Prdm16, which controls the development of adipocytes and the acquisition of the thermo- genic function and phenotype of BAT (25, 40) , as well as Ucp3, which participates not only in lipid metabolism and defense against reactive oxygen species, but also in adaptive thermogenesis (45) . This observation is in agreement with a role of leptin stimulating the expression of Ucp3 (37) .
NO regulates several aspects of mitochondrial function, including control of respiration and mitochondrial biogenesis (46) , although its physiological role in modulating mitochondrial content remains unclear. It is well known that NO induces mitochondrial biogenesis by the activation of PGC-1␣ and cyclic guanosine 3=, 5=-monophosphate at the same time as it regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase (4) . The increased NO levels in response to induction of iNOS produce a detrimental loss of control of the NO-cytochrome c oxidase pathway together with an increased production of reactive nitrogen species leading to a cellular damage and mitochondrial dysfunction (59) . We found an increased expression of genes related to sulfate transport (Tst), genes implicated in protein transmembrane transport (Slc family), as well as genes involved in lipid metabolism in iNOS-deficient mice. Furthermore, iNOS ablation in ob/ob mice downregulated the expression of the translocase Timm22, but the number of genes repressed in DBKO mice was lower than in ob/ob mice. This suggests that iNOS absence does not totally reverse the impaired mitochondrial function of leptin deficiency. The Venn diagram reveals that only six genes with altered expression were common between the three comparisons. We observed changes in the expression of genes involved in catabolic processes such as the tumor suppressor Ovca2 or Ube2w, which codifies for a member of the E2 family that catalyzes the ubiquitin-mediated proteolysis of several proteins. We also found alterations in Gstm2 and in the T cell-specific GTPase Tgtp, which participate in immune response, and in genes involved in the transmembrane transport of proteins (Timm22).
The major change in gene expression was observed in Med1, with leptin-deficiency diminishing its expression, whereas the lack of the iNOS gene increased it twofold. Med1, also known as Pparbp or Trap220, is implicated in the transcriptional control of gene regulation and exerts an important role in energy homeostasis (14) . Nuclear receptors are transcription factors broadly involved in many biological processes such as metabolism, development, or reproduction and are activated by different ligands in various signaling pathways. Its activity as activators or repressors depends on its interaction with several co-regulators that may also be regulated by various signaling cascades. The Mediator complex is composed of at least 25-30 subunits and works as a transcriptional factor, interacting directly on the general transcription machinery (3). Med1 is the main component of Mediator that interacts with different nuclear hormone receptors (Fig. 4C) . It has been shown that Med1 is required for PPAR␥-stimulated adipogenesis (33, 34) . Med1 exerts a considerable influence on the functions of several nuclear receptors such as PPAR␣, RAR␣, RXR, or ER␣ and their target genes. Due to the interactions of Med1 with a variety of transcriptional factors including tumor suppressor p53, p300, Pgc-1␣, and C/EBP␤, this cofactor is implicated in cell development, energetic homeostasis, and adipogenesis (13) . Deletion of the iNOS gene in ob/ob mice significantly increases the expression of Med1, suggesting an improvement in energy homeostasis in DBKO. These data are in accordance with a previous study of our group showing that deletion of the iNOS gene in ob/ob mice causes an improvement in the brown-like phenotype and the molecular function of BAT (2) .
In the present study we have identified several molecules involved in the amelioration of the obese phenotype after iNOS deletion. Of particular interest, Med1, which is elevated in ob/ob mice in the absence of the iNOS gene, exerts a functional repercussion on the improvement of energy balance in the DBKO mice.
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